These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37386985)

  • 1. Evaluation of Completeness, Comparability, Validity, and Timeliness in Cancer Registries: A Scoping Review.
    Shokrizadeharani L; Batooli Z; Heydarian S; Sharif R; Ghaderkhany S; Tamehbidgoli M; Ataiejahanbegloo F; Hieber D; Kuhn P
    Stud Health Technol Inform; 2023 Jun; 305():160-163. PubMed ID: 37386985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Cancer Database Conforms to the Standardized Framework for Registry and Data Quality.
    Palis BE; Janczewski LM; Browner AE; Cotler J; Nogueira L; Richardson LC; Benard V; Wilson RJ; Walker N; McCabe RM; Boffa DJ; Nelson H
    Ann Surg Oncol; 2024 Sep; 31(9):5546-5559. PubMed ID: 38717542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Fung JW; Lim SB; Zheng H; Ho WY; Lee BG; Chow KY; Lee HP
    Cancer Epidemiol; 2016 Aug; 43():76-86. PubMed ID: 27399312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity.
    Moberger P; Sköldberg F; Birgisson H
    Acta Oncol; 2018 Dec; 57(12):1611-1621. PubMed ID: 30477372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of data quality in the Swedish National Register for Breast Cancer.
    Löfgren L; Eloranta S; Krawiec K; Asterkvist A; Lönnqvist C; Sandelin K;
    BMC Public Health; 2019 May; 19(1):495. PubMed ID: 31046737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of data quality in the Swedish National Penile Cancer Register.
    Warnolf Å; Glombik D; Sandin F; Lambe M; Baseckas G; Gerdtsson A; Kohestani K; Kirrander P
    Scand J Urol; 2024 Oct; 59():162-168. PubMed ID: 39356203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of data quality in the National Swedish Kidney Cancer Register.
    Landberg A; Bruce D; Lindblad P; Ljungberg B; Lundstam S; Thorstenson A; Sundqvist P
    Scand J Urol; 2021 Apr; 55(2):142-148. PubMed ID: 33599561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data quality in Brazilian population-based cancer registries for gastrointestinal cancers.
    E Silva DRM; de Oliveira MM; Curado MP
    BMC Cancer; 2024 Jul; 24(1):870. PubMed ID: 39030476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of data quality in trauma registries: A systematic review.
    Porgo TV; Moore L; Tardif PA
    J Trauma Acute Care Surg; 2016 Apr; 80(4):648-58. PubMed ID: 26881490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The completeness and timeliness of cancer registration and the implications for measuring cancer burden.
    Donnelly C; Cairnduff V; Chen JJ; Kearney T; Fitzpatrick D; Fox C; Gavin A
    Cancer Epidemiol; 2017 Aug; 49():101-107. PubMed ID: 28600946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Dimitrova N; Parkin DM
    Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
    Bray F; Parkin DM
    Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completeness and timeliness: Cancer registries could/should improve their performance.
    Zanetti R; Schmidtmann I; Sacchetto L; Binder-Foucard F; Bordoni A; Coza D; Ferretti S; Galceran J; Gavin A; Larranaga N; Robinson D; Tryggvadottir L; Van Eycken E; Zadnik V; Coebergh JW; Rosso S
    Eur J Cancer; 2015 Jun; 51(9):1091-8. PubMed ID: 24393522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.
    Prang KH; Karanatsios B; Verbunt E; Wong HL; Yeung J; Kelaher M; Gibbs P
    Contemp Clin Trials; 2022 Aug; 119():106843. PubMed ID: 35792338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data Quality in Rare Diseases Registries.
    Kodra Y; Posada de la Paz M; Coi A; Santoro M; Bianchi F; Ahmed F; Rubinstein YR; Weinbach J; Taruscio D
    Adv Exp Med Biol; 2017; 1031():149-164. PubMed ID: 29214570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of data quality at the National Cancer Registry of Ukraine.
    Ryzhov A; Bray F; Ferlay J; Fedorenko Z; Goulak L; Gorokh Y; Soumkina O; Znaor A
    Cancer Epidemiol; 2018 Apr; 53():156-165. PubMed ID: 29459256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours.
    Leinonen MK; Miettinen J; Heikkinen S; Pitkäniemi J; Malila N
    Eur J Cancer; 2017 May; 77():31-39. PubMed ID: 28350996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland.
    Wanner M; Matthes KL; Korol D; Dehler S; Rohrmann S
    Biomed Res Int; 2018; 2018():7656197. PubMed ID: 30009174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparability, diagnostic validity and completeness of Nigerian cancer registries.
    al-Haddad BJ; Jedy-Agba E; Oga E; Ezeome ER; Obiorah CC; Okobia M; Ogunbiyi JO; Ukah CO; Omonisi A; Nwofor AM; Igbinoba F; Adebamowo C
    Cancer Epidemiol; 2015 Jun; 39(3):456-64. PubMed ID: 25863982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.